$73.2 Million is the total value of Ponoi Management, LLC's 4 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics Inc | $38,482,000 | +31.8% | 1,599,417 | 0.0% | 52.54% | +14.0% | |
| NGM | NGM Biopharmaceuticals Inc | $16,990,000 | +2.0% | 1,298,908 | 0.0% | 23.20% | -11.8% | |
| RVMD | Revolution Medicines Inc | $13,508,000 | +1.2% | 685,011 | 0.0% | 18.44% | -12.5% | |
| NRIX | Nurix Therapeutics Inc | $4,262,000 | +2.8% | 327,123 | 0.0% | 5.82% | -11.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RAPT Therapeutics Inc | 8 | Q3 2022 | 54.2% |
| NGM Biopharmaceuticals Inc | 8 | Q3 2022 | 26.3% |
| Revolution Medicines Inc | 8 | Q3 2022 | 22.7% |
| Nurix Therapeutics Inc | 8 | Q3 2022 | 14.9% |
| Constellation Pharmaceuticals Inc. | 3 | Q2 2021 | 35.3% |
View Ponoi Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-08 |
| 4 | 2023-11-17 |
| 4 | 2023-02-01 |
| 4 | 2023-01-25 |
| 4 | 2023-01-23 |
| 4 | 2023-01-17 |
| 4 | 2023-01-12 |
| 4 | 2022-12-14 |
| 4 | 2022-11-23 |
| 13F-HR | 2022-11-14 |
View Ponoi Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.